[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Park et al., 2016 - Google Patents

Characterization of the reversed-phase chromatographic behavior of PEGylated peptides based on the poly (ethylene glycol) dispersity

Park et al., 2016

Document ID
2756927813507226275
Author
Park E
Na D
Publication year
Publication venue
Analytical chemistry

External Links

Snippet

The separation mechanism of PEGylated peptides in reversed-phase high-performance liquid chromatography (RP-HPLC) is complex, because the PEGylated molecules exhibit physicochemical properties that are different from those of the parent molecules and have …
Continue reading at pubs.acs.org (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A61K47/48192—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes
    • A61K47/48215—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule the organic macromolecular compound has been obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas, polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer, dendrimer, e.g. PEG, PPG, PEO, polyglycerol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials

Similar Documents

Publication Publication Date Title
Park et al. Characterization of the reversed-phase chromatographic behavior of PEGylated peptides based on the poly (ethylene glycol) dispersity
Wang et al. High resolution capillary isoelectric focusing mass spectrometry analysis of peptides, proteins, and monoclonal antibodies with a flow-through microvial interface
Qi et al. A brush-polymer/exendin-4 conjugate reduces blood glucose levels for up to five days and eliminates poly (ethylene glycol) antigenicity
Fekete et al. Chromatographic, electrophoretic, and mass spectrometric methods for the analytical characterization of protein biopharmaceuticals
Redman et al. Characterization of intact antibody drug conjugate variants using microfluidic capillary electrophoresis–mass spectrometry
da Silva Freitas et al. Chemical and enzymatic site specific PEGylation of hGH
Huang et al. Characterization of poly (ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines
Beck et al. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future
Stejskal et al. Suppression of peptide sample losses in autosampler vials
Lawrence et al. Criteria for selecting PEGylation sites on proteins for higher thermodynamic and proteolytic stability
Mero et al. Transglutaminase-mediated PEGylation of proteins: direct identification of the sites of protein modification by mass spectrometry using a novel monodisperse PEG
Xu et al. Automated capillary isoelectric focusing-mass spectrometry with ultrahigh resolution for characterizing microheterogeneity and isoelectric points of intact protein complexes
van der Heeft et al. A Microcapillary Column Switching HPLC− Electrospray Ionization MS System for the Direct Identification of Peptides Presented by Major Histocompatibility Complex Class I Molecules
Maiser et al. Isoform separation and binding site determination of mono-PEGylated lysozyme with pH gradient chromatography
Matsuda et al. Comparison of analytical methods for antibody–drug conjugates produced by chemical site-specific conjugation: first-generation AJICAP
D’Atri et al. Orthogonal middle-up approaches for characterization of the glycan heterogeneity of etanercept by hydrophilic interaction chromatography coupled to high-resolution mass spectrometry
Chen et al. Native reversed-phase liquid chromatography: a technique for LCMS of intact antibody–drug conjugates
Dada et al. High-resolution capillary zone electrophoresis with mass spectrometry peptide mapping of therapeutic proteins: peptide recovery and post-translational modification analysis in monoclonal antibodies and antibody–drug conjugates
Forstenlehner et al. A direct-infusion-and HPLC-ESI-Orbitrap-MS approach for the characterization of intact PEGylated proteins
Güray et al. Mass spectrometry of intact proteins reveals+ 98 u chemical artifacts following precipitation in acetone
Meert et al. Characterization of antibody charge heterogeneity resolved by preparative immobilized pH gradients
Noort et al. Characterization of sulfur mustard induced structural modifications in human hemoglobin by liquid chromatography− tandem mass spectrometry
Forstenlehner et al. Site-specific characterization and absolute quantification of Pegfilgrastim oxidation by top-down high-performance liquid chromatography–mass spectrometry
Chen et al. Top-down analysis of branched proteins using mass spectrometry
Conduah Birt et al. Stable acetaldehyde− protein adducts as biomarkers of alcohol exposure